Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

NCT02314156 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

BRCA1 Mutation Carrier
BRCA2 Mutation Carrier
Ductal Breast Carcinoma In Situ
Lobular Breast Carcinoma In Situ
Stage 0 Breast Cancer
Stage IA Breast Cancer
Stage IB Breast Cancer
Stage IIA Breast Cancer
Stage IIB Breast Cancer

Interventions

DRUG: Telapristone Acetate
OTHER: Placebo
DRUG: Telapristone Acetate
OTHER: Placebo
OTHER: Laboratory Biomarker Analysis
OTHER: Questionnaire Administration

Sponsor

Northwestern University

Collaborators

[object Object]